Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flow from operating activities:
Net loss	$ (7,345,170)	$ (13,762,039)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	417,989	649,441
Vesting expense	15,159	75,901
Common stock issued for consulting and other	79,280	212,792
Gain on valuation of equity-linked instruments and derivative liability	(8,261)	(97,162)
Loss on impairment of goodwill	0	7,231,093
Loss on impairment of property and equipment	162,905	0
Loss on property and equipment disposal	903	1,700
Changes in assets and liabilities:
Accounts receivable	(99,653)	17,799
Inventories	36,795	(86,931)
Prepaid expense and other assets	47,090	(157,827)
Accounts payable	66,109	(38,104)
Accrued expenses	(401,002)	(441,328)
Contract liabilities	25,823	(29,457)
Other long-term liabilities	0	(3,684)
Net cash used in operating activities:	(7,002,033)	(6,427,806)
Cash flow from investing activities:
Purchase of property and equipment	(279,727)	(233,572)
Acquisition of intangibles	(26,018)	(34,844)
Net cash used in investing activities:	(305,745)	(268,416)
Cash flow from financing activities:
Proceeds from issuance of common stock and warrants, net	0	6,507,050
Proceeds from issuance of common stock pursuant to equity line	0	236,009
Net cash provided by financing activities	0	6,743,059
Net increase (decrease) in cash and cash equivalents	(7,307,778)	46,837
Cash and cash equivalents at beginning of period	22,071,523	28,202,615
Cash and cash equivalents at end of period	14,763,745	28,249,452
Supplemental disclosure for cash flow information:
Cash payments for interest	0	1,439
Non-cash transactions:
Right-of-use assets obtained in exchange for lease liabilities	2,997,181	0
Series F Preferred Stock dividend	794	0
Common stock issued to settle accrued board of directors’ and advisory board compensation	189,896	0
Purchase of property & equipment accrued in accounts payable	3,920	0
Redemption of Series F Preferred Stock	794	0
Common stock issued in connection with reverse stock split	189,896	0
Reverse Stock Split [Member]
Non-cash transactions:
Common stock issued to settle accrued board of directors’ and advisory board compensation	253	0
Common stock issued in connection with reverse stock split	$ 253	$ 0